Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III

K-Number: K894338 · 1989-07-25

ApplicantAnalytical Control Systems, Inc.
Decision Date1989-07-25
Product CodeGGC
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III is the device name listed in this FDA 510(k) record. The listed applicant is Analytical Control Systems, Inc.. It received FDA 510(k) clearance on 1989-07-25 under 510(k) number K894338. The device is classified under product code GGC. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III?

ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III is a medical device that received FDA 510(k) clearance on 1989-07-25. The listed applicant is Analytical Control Systems, Inc.. The 510(k) number is K894338.

When did ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III receive FDA 510(k) clearance?

ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III received FDA 510(k) clearance on 1989-07-25, under 510(k) number K894338.

Who is the listed applicant for ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III?

The FDA 510(k) record lists Analytical Control Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III?

The FDA product code for ACS ANIMAL PLASMA COAGULATION CONTROL LEVEL III is GGC.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Analytical Control Systems, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K961892SPECKTIN-LA TEST SETK941115ACS CARDIO-TROL CONTROLK940272ACS NORMAL ANGIOTENSIN CONVERTING ENZYME CONTROLK940397ACS O DILVENT PROTEIN DILUTION MATRIXK930477ACS ANGIOTENSIN CONVERTING ENZYME (ACE) CALIBRATORK926012ACS APCT REAGENT, MODIFIED

View all 42 devices →

Related Devices (Code: GGC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K102552HEMOSIL LA POSITIVE CONTROLInstrumentation Laboratory COK100103SPECIALTY ASSAYED CONTROL-2Helena LaboratoriesK062306PLASMACON N, PLASMACON L-1, PLASMACON L-2R2 Diagnostics, Inc.K061803STA - CONTROL LA 1+2Diagnostica Stago, Inc.K032804CRYOCHECK WEAK LUPUS POSITIVE CONTROLPrecision BiologicK023312CONTROL PLASMA PDade Behring, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑